Cargando…
A Pilot Study of Sirolimus in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTEN
LESSONS LEARNED. This is the first human interventional study in patients with Cowden syndrome that is driven by inactivation of germline PTEN gene. Single‐agent sirolimus, a mTOR inhibitor, suppressed mTOR signaling in surrogate human tissues without significant toxicity. BACKGROUND. Cowden syndrom...
Autores principales: | Komiya, Takefumi, Blumenthal, Gideon M., DeChowdhury, Roopa, Fioravanti, Susan, Ballas, Marc S., Morris, John, Hornyak, Thomas J., Wank, Stephen, Hewitt, Stephen M., Morrow, Betsy, Memmott, Regan M., Rajan, Arun, Dennis, Phillip A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975943/ https://www.ncbi.nlm.nih.gov/pubmed/31350329 http://dx.doi.org/10.1634/theoncologist.2019-0514 |
Ejemplares similares
-
Hidden association of Cowden syndrome, PTEN mutation and meningioma frequency
por: Yakubov, Eduard, et al.
Publicado: (2016) -
First Polish Cowden syndrome patient with confirmed PTEN gene mutation
por: Podralska, Marta, et al.
Publicado: (2010) -
Characterization of cryptic splicing in germline PTEN intronic variants in Cowden syndrome
por: Chen, Hannah Jinlian, et al.
Publicado: (2017) -
A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors
por: Blumenthal, Gideon M., et al.
Publicado: (2014) -
Cowden Syndrome with a Novel Germline PTEN Mutation and an Unusual Clinical Course
por: Seol, Jung Eun, et al.
Publicado: (2015)